Community Academic Profiles–

Douglas Owens

Back to Profile

Publication Details

  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

    Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M, Owens DK. N Engl J Med. 2005; 352 (6): 570-85

    The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined.

    PubMedID: 15703422

Stanford Medicine Resources:

Footer Links: